Financials Pro-Dex, Inc.

Stocks

PDEX

US74265M2052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-09-23 EDT			5-day change	1st Jan Change
71.94 ^USD	-0.65%		+0.13%	+86.95%

09-20	Pro-Dex, Inc.(NasdaqCM:PDEX) added to S&P Global BMI Index	CI
09-11	Pro Dex Insider Sold Shares Worth $1,165,290, According to a Recent SEC Filing	MT

Projected Income Statement: Pro-Dex, Inc.

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	42.04	46.09	53.84	66.59	77.55	82.7	86.8
Change	-	9.62%	16.83%	23.68%	16.45%	6.64%	4.96%
EBITDA ¹	7.159	7.385	8.938	12.48	15.07	15.5	17.5
Change	-	3.16%	21.03%	39.66%	20.75%	2.83%	12.9%
EBIT ¹	5.158	5.762	7.173	10.69	12.99	14	16
Change	-	11.71%	24.49%	49.02%	21.54%	7.77%	14.29%
Interest Paid ¹	-0.464	-0.533	-0.558	-0.829	-0.812	-0.7	-0.7
Earnings before Tax (EBT) ¹	4.706	9.428	2.634	12.06	18.02	13.3	15.3
Change	-	100.34%	-72.06%	357.78%	49.4%	-26.17%	15.04%
Net income ¹	3.855	7.074	2.127	8.978	13.66	10.6	12.2
Change	-	83.5%	-69.93%	322.1%	52.17%	-22.41%	15.09%
Announcement Date	9/8/22	10/13/23	9/5/24	9/4/25	9/3/26	-	-

¹USD in Million

Estimates

Fiscal Period: June	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2	2028 Q3	2028 Q4
Net sales ¹	9.988	10.17	9.265	12.62	11.09	11.28	13.08	10.64	11.94	12.59	14.29	15.02	14.89	16.79	17.41	17.49	18.53	-	20.4	20.4	20.5	20.7	21	21.4	21.6	21.8	22.1
Change	-	1.85%	-8.93%	36.16%	-12.11%	1.76%	15.93%	-18.66%	12.21%	5.44%	13.54%	5.12%	-0.89%	12.77%	3.7%	0.46%	5.92%	-	-	-0.02%	0.49%	0.98%	1.45%	1.9%	0.93%	0.93%	1.38%
EBITDA ¹	1.802	2.059	1.572	1.727	1.35	1.499	2.481	2.055	2.303	1.261	2.701	2.675	3.428	3.135	4.108	1.812	3.581	-	4.112	3.4	3.6	4.1	4.4	4	4.2	4.5	4.8
Change	-	14.26%	-23.65%	9.86%	-21.83%	11.04%	65.51%	-17.17%	12.07%	-45.25%	114.2%	-0.96%	28.15%	-8.55%	31.04%	-55.89%	97.63%	-	-	-17.32%	5.88%	13.89%	7.32%	-9.09%	5%	7.14%	6.67%
EBIT ¹	1.318	1.602	1.035	1.204	0.95	1.137	2.065	1.61	1.833	0.777	2.213	2.352	3.013	2.692	3.64	1.344	3.109	-	3.529	3	3.2	3.7	4	3.6	3.8	4.1	4.4
Change	-	21.55%	-35.39%	16.33%	-21.1%	19.68%	81.62%	-22.03%	13.85%	-57.61%	184.81%	6.28%	28.1%	-10.65%	35.22%	-63.08%	131.32%	-	-	-14.99%	6.67%	15.62%	8.11%	-10%	5.56%	7.89%	7.32%
Charge d'intérêts ¹	-	-	-0.112	-0.115	-0.13	-0.121	-0.131	-0.144	-0.133	-0.139	-0.138	-0.15	-0.152	-0.204	-0.246	-0.226	-0.2	-	-0.271	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2
Earnings before Tax (EBT) ¹	1.371	1.21	0.634	1.492	1.294	1.174	1.768	5.192	-0.829	0.62	0.913	1.93	3.319	2.586	4.554	1.599	6.222	-	3.525	2.8	3.1	3.6	3.8	3.4	3.7	4	4.2
Change	-	-11.74%	-47.6%	135.33%	-13.27%	-9.27%	50.6%	193.67%	-115.97%	174.79%	47.26%	111.39%	71.97%	-22.08%	76.1%	-64.89%	289.12%	-	-	-20.57%	10.71%	16.13%	5.56%	-10.53%	8.82%	8.11%	5%
Net income ¹	1.064	0.925	0.462	0.641	1.076	0.879	1.313	3.806	-0.615	0.5	0.655	1.587	2.466	2.04	3.275	1.196	4.68	3.938	2.857	2.3	2.5	2.8	3.1	2.7	2.9	3.2	3.4
Change	-	-13.06%	-50.05%	38.74%	67.86%	-18.31%	49.37%	189.87%	-116.16%	181.3%	31%	142.29%	55.39%	-17.27%	60.54%	-63.48%	291.3%	-15.85%	-27.45%	-19.5%	8.7%	12%	10.71%	-12.9%	7.41%	10.34%	6.25%
Announcement Date	11/15/21	2/3/22	5/5/22	9/8/22	11/3/22	2/2/23	5/4/23	10/13/23	11/2/23	2/8/24	5/2/24	9/5/24	10/31/24	1/30/25	5/1/25	9/4/25	10/30/25	4/30/26	9/3/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Pro-Dex, Inc.

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	9/8/22	10/13/23	9/5/24	9/4/25	9/3/26	-	-

Estimates

Cash Flow Forecast: Pro-Dex, Inc.

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	1.638	0.974	0.983	1.246	0.483	1.2	1.2
Change	-	-40.54%	0.92%	26.75%	-61.24%	148.45%	0%
Free Cash Flow (FCF) ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	9/8/22	10/13/23	9/5/24	9/4/25	9/3/26	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Pro-Dex, Inc.

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	17.03%	16.02%	16.6%	18.75%	19.44%	18.74%	20.16%
EBIT Margin (%)	-	12.27%	12.5%	13.32%	16.05%	16.75%	16.93%	18.43%
EBT Margin (%)	-	11.19%	20.46%	4.89%	18.11%	23.23%	16.08%	17.63%
Net margin (%)	-	9.17%	15.35%	3.95%	13.48%	17.62%	12.82%	14.06%
FCF margin (%)	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-
Profitability
ROA	7.92%	7.36%	7.14%	8.6%	11.75%	11.97%	-	-
ROE	22.74%	17.62%	24.81%	6.81%	26.6%	32.43%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	3.9%	2.11%	1.83%	1.87%	0.62%	1.45%	1.38%
CAPEX / EBITDA (%)	-	22.88%	13.19%	11%	9.98%	3.2%	7.74%	6.86%
CAPEX / FCF (%)	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	6.51	8.784	9.177	11.23	14.36	16.76	19.33
Change	-	-	34.94%	4.47%	22.4%	27.84%	16.71%	15.33%
EPS ¹	-	1.02	1.95	0.6	2.67	4.12	3.09	3.36
Change	-	-	91.18%	-69.23%	345%	54.31%	-25%	8.74%
Nbr of stocks (in thousands)	-	3,619	3,545	3,419	3,261	3,193	3,203	3,203
Announcement Date	-	9/8/22	10/13/23	9/5/24	9/4/25	9/3/26	-	-